arrow
H

Hansjürgen Agostini

University of Freiburg
H指数:45
被引数:6,581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline factors that are associated with change in visual acuity in intermediate AMD over two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 2

与欧洲多中心队列研究INTERCEPT-AMD报告2中,两年期间中度高龄黄斑变性(AMD)患者视力变化相关的基线因素。

Eye
IF3.2
2025-10-170
OA
Significant increase of firework induced eye injuries in Germany and The Netherlands- are we doing enough to protect minors and bystanders? (vol 263, pg 1157, 2025)

德国和荷兰烟花引起的眼部伤害显著增加——我们是否已足够保护未成年人及旁观者?(卷263,页1157,2025)

2025-10-010
OAAI
Visual acuity in various phenotypes of intermediate age related macular degeneration (AMD) in a multicentre cohort study in Europe- INTERCEPT-AMD report 1

欧洲多中心队列研究中的中度高龄相关性黄斑变性(AMD)不同表型的视力敏锐度—INTERCEPT-AMD报告1

Eye
IF3.2
2025-07-190
OA
A randomized, double-masked parallel-group, multicenter clinical study evaluating the efficacy and safety of the biosimilar candidate AVT06 compared to the reference product aflibercept in participants with neovascular age-related macular degeneration

一项随机、双盲、平行组、多中心临床研究,评估生物类似药候选药物AVT06相较于参考药物aflibercept在新生血管性年龄相关性黄斑变性患者中的有效性与安全性。

2025-06-170
OA
Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakage

微囊相关蛋白4的药理学阻断可减少视网膜新生血管形成和血管渗漏

2025-01-010
OAAI
Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial
2024-06-253
PRE
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy Results from a Randomized Clinical Trial
2022-10-0113
PRE
Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy
2022-05-1713
OAAI